Foundayo vs Wegovy Pill: Which Oral Weight-Loss Tablet Is Right for You?
Foundayo is a daily orforglipron tablet with no food or water restrictions. Take the Wegovy pill after at least 8 hours without food, swallow it whole with no more than 120 mL of water, then wait at least 30 minutes before food, drink or other oral medicines. Both are available through Happy Pharmacy after clinical assessment and prescriber approval. Their weight-loss studies were separate trials, so the figures below are context for a consultation, not a direct test of which tablet is better.
This is where the two medicines genuinely diverge, and it comes down to their underlying chemistry. Foundayo is a small, non-peptide molecule, while the Wegovy pill delivers a peptide (semaglutide, the same active ingredient as the Wegovy injection) with an ingredient called SNAC that helps semaglutide absorption in the stomach. That difference in formulation is exactly why their administration requirements are so different.
| Foundayo | Wegovy Pill | |
|---|---|---|
| Manufacturer | Eli Lilly | Novo Nordisk |
| Active ingredient | Orforglipron (small molecule) | Semaglutide (peptide) |
| Food/water restriction | None — any time of day | At least 8 hours fasting; up to 120 mL water; then wait at least 30 minutes |
| Absorption enhancer needed | No | Yes (SNAC) |
Why this matters day to day
For many people, the Wegovy pill's fasting requirement is manageable with a consistent morning routine — take it, wait, then have breakfast. But for anyone with an irregular schedule, shift work, or who simply doesn't want to plan their morning around a tablet, Foundayo's complete lack of food or water restriction is a genuine, practical advantage.
It's important to be upfront here: Foundayo and the Wegovy pill haven't been tested against each other in a head-to-head trial, so any comparison is between two separate trials with different designs, populations and timeframes — not a controlled, direct comparison.
| Foundayo (ATTAIN-1) | Wegovy Pill (OASIS 4) | |
|---|---|---|
| Trial duration | 72 weeks | 64 weeks |
| Average weight loss: overall analysis | 11.2% (36 mg trial capsule, equivalent to 17.2 mg tablet) | 13.6% (25 mg tablet) |
| Estimate assuming treatment continued | 12.4% | 16.6% |
| Placebo weight loss: overall analysis | 2.1% | 2.2% |
| Participants achieving ≥20% weight loss | 18.4% (overall analysis) | 27.5% (overall analysis) |
The main row uses analyses that include the effects of stopping treatment: the ATTAIN-1 treatment-regimen estimate and the OASIS 4 treatment-policy estimate. The second row answers a different question by estimating results if treatment continued. This explains why you may also see 12.4% for Foundayo and 16.6% for the Wegovy pill. These are separate trials in adults without type 2 diabetes, with different populations, durations and analysis methods. They cannot establish which medicine will work better for an individual. All treatments were studied alongside diet and physical activity.
| Foundayo | Wegovy Pill | |
|---|---|---|
| Starting dose | 0.8mg | 1.5mg |
| Dose levels, including starting dose | 6 | 4 |
| Minimum time per step | 30 days | 1 month |
| Maximum dose | 17.2mg | 25mg |
Foundayo progresses through 0.8, 2.5, 5.5, 9, 14.5 and 17.2 mg once daily, with at least 30 days before each increase. Reaching 17.2 mg therefore takes at least 150 days. The Wegovy pill progresses through 1.5, 4 and 9 mg for at least one month each before 25 mg, so its earliest maintenance dose starts after three months. Increases depend on response and tolerability; follow your prescription. See our Foundayo dosage and titration guide.
Side Effects ComparedBoth can cause nausea, diarrhoea, vomiting, constipation and indigestion, often during dose increases. The available evidence does not establish that the presence or absence of SNAC makes one tablet better tolerated. Your previous side effects and medical history matter when choosing treatment.
Interaction advice differs between medicines. Foundayo users taking an oral hormonal contraceptive should use a non-oral method or add a barrier method for 30 days after starting and after every dose increase. The Wegovy tablet prescribing information reports no clinically relevant effect on the oral contraceptives studied, although vomiting or diarrhoea can affect pill reliability. Ask your pharmacist to check all medicines and contraception. See our Foundayo side effects guide.
Important
Neither medicine should be combined with another GLP-1 receptor agonist medicine, including each other, Mounjaro, or the Wegovy injection. If you're considering switching between any of these treatments, your prescriber must decide the timing and dose; there is no single switching interval that applies to every treatment.
The Wegovy injection has a UK indication for reducing major cardiovascular events in eligible adults with established cardiovascular disease and overweight or obesity. The current UK Wegovy tablet and Foundayo indications do not include this specific cardiovascular risk-reduction indication. Sharing an ingredient or improving weight does not make these licences interchangeable. Your prescriber can advise which option fits your medical history.
If You're Already on Another GLP-1 MedicineIf you currently use Mounjaro or the Wegovy injection, a change needs a prescriber-led plan: the starting dose and timing depend on your current medicine, dose, response and side effects. Do not overlap treatments or calculate your own equivalent dose. There is a specific licensed pathway from Wegovy 2.4 mg weekly injections to 25 mg daily tablets, starting one week after the last injection, if your prescriber considers it suitable. This does not apply automatically to other medicines or doses. ATTAIN-MAINTAIN studied selected patients who had completed an injection trial. Switching to orforglipron preserved more of their earlier weight loss than switching to placebo, but some weight regain occurred. This does not guarantee that someone switching in routine care will keep all their previous weight loss. Before discussing a change, compare the practical routines in our weight loss pills vs injections guide.
A Genuinely New Kind of ChoiceUntil relatively recently, anyone wanting a GLP-1 medicine in the UK had one real choice to make: which injection. The arrival of two chemically different oral options — not just two brands of the same molecule — is a genuinely new situation for UK patients. Foundayo and the Wegovy pill aren't simply competing versions of the same tablet; they represent two different scientific approaches (small-molecule vs peptide) to the same underlying goal, each with its own trade-offs in convenience, trial results, and manufacturer backing. Neither is a straightforwardly "better" choice in the abstract — the right one depends on what matters most to you, and that's exactly the kind of decision a proper consultation is designed to help with, rather than a trial statistic on its own. Our orforglipron UK availability update explains approval, private supply and NHS access for Foundayo.
Prices and Pack Sizes at Happy PharmacyFoundayo pill prices range from £94.49 on subscription or £104.99 as a single purchase at 0.8 mg, to £175.49 or £194.99 respectively at 17.2 mg. Each pack contains 30 tablets for 30 days of once-daily treatment.
Wegovy pill prices start at £98.99 on subscription or £109.99 as a single purchase for 1.5 mg. The 25 mg pack costs £175.49 or £194.99 respectively. Each pack contains 30 tablets for 30 days of once-daily treatment.
Happy Pharmacy prices checked 1 October 2026 and subject to change. Compare the same purchase option and pack duration, and check delivery options and any charges at checkout. Consultation is free. The doses shown illustrate pricing; your prescriber decides which medicine and dose are suitable. Twelve 30-day tablet packs cover 360 days; thirteen 28-day injection packs cover 364 days.
Which Might Suit You BetterIf you are also considering a weekly injection, our Foundayo vs Mounjaro guide compares orforglipron with tirzepatide, including treatment routines and the limits of comparing results from separate trials. Our Wegovy pill vs Mounjaro guide covers the corresponding comparison with oral semaglutide.
Foundayo may suit you if…
- You have an unpredictable schedule and don't want to plan your morning around a fasting window
- You prefer a daily tablet without a fasting routine, subject to a medicine and interaction review
- You want to discuss an available oral treatment with a prescriber
The Wegovy Pill may suit you if…
- You want to discuss oral semaglutide with a prescriber
- You already have a consistent morning routine and don't mind the empty-stomach requirement
- Your prescriber considers semaglutide appropriate for your medical history and treatment goals
For a wider view of oral and injectable options, see our weight loss medications overview.
Discuss Your Tablet Options With a Prescriber
Foundayo and the Wegovy pill are available through Happy Pharmacy following a free online consultation and prescriber approval. Your assessment will help determine whether either treatment is suitable.
Start Your Free Online Consultation →Read about treatment formats, listed prices and the assessment process at Happy Pharmacy. A prescriber will assess whether any treatment is suitable for you.
Weight loss medicationsUse code SWITCH10 if you're switching from another providerHappy Pharmacy is a GPhC-registered pharmacy (No. 9012585) — Superintendent Pharmacist: Palvinder Deol — Rated 4.8★ Excellent on Trustpilot